ALemtuzumab
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4236 publications
Keratinocyte Carcinoma Risk: Antithymocyte Globulin vs. Other Induction Therapy in Solid Organ Transplant Patients: A Meta-Analysis.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: August 19, 2026
A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.
Journal: Science translational medicine
Published: August 19, 2026
Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.
Journal: Health technology assessment (Winchester, England)
Published: August 11, 2026
Precision medicine guided development of new immunosuppression strategies in solid organ transplantation.
Journal: Current opinion in organ transplantation
Published: June 25, 2026
Accelerated desensitization enables HLA-incompatible deceased donor kidney transplant in a highly sensitized pediatric recipient.
Journal: Human immunology
Published: June 24, 2026
Letermovir for Cytomegalovirus Prophylaxis in Patients With T-PLL Treated With Alemtuzumab.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 23, 2026
Targeting the cytokine storm: new therapies in the treatment of paediatric haemophagocytic lymphohistiocytosis.
Journal: Expert review of clinical immunology
Published: June 18, 2026
Targeting the cytokine storm: new therapies in the treatment of pediatric hemophagocytic lymphohistiocytosis.
Journal: Expert review of clinical immunology
Published: June 18, 2026
Conditioning Intensity and Outcomes in Pediatric HLA-Identical Transplant for Sickle Cell Disease: Comparison of MAC, RIC, and NMA.
Journal: Transplantation and cellular therapy
Published: June 03, 2026
Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: May 25, 2026
Alemtuzumab Induction via Intravenous vs. Subcutaneous Administration in Pediatric Kidney Transplantation.
Journal: Pediatric transplantation
Published: May 21, 2026
Alemtuzumab-based HLA-haploidentical transplantation for relapsed/refractory aggressive NK-cell leukemia
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 13, 2026
Last Updated: 09/26/2026